Allscripts (MDRX) reported Q3 EPS of $0.23, $0.04 better than the analyst estimate of $0.19. Revenue for the quarter came in at $152 million versus the consensus estimate of $152.8 million.
Allscripts (MDRX) reported Q3 EPS of $0.23, $0.04 better than the analyst estimate of $0.19. Revenue for the quarter came in at $152 million versus the consensus estimate of $152.8 million.